Getting the compensation you deserve
Seeger Weiss is a trial firm. What separates our firm from most others is that we litigate each and every case as if it is going to “go the distance.” Our reputation as a trial firm is well known within the legal community and to defense firms and insurance companies across the bar. This reputation, and our willingness to fight for our clients’ rights through trial, is of paramount importance to reaching our ultimate goal of obtaining fair and just compensation for your injuries.
Nexium & Prilosec Lawsuit
Prescription heartburn medications may be linked to kidney failure and chronic kidney disease.
Mercedes BlueTEC Lawsuit
BlueTEC Clean Diesel cars were marketed as “environmentally-friendly,” but cheat emissions tests.
The US FDA has announced new warnings about an increased risk of diabetic ketoacidosis after taking Invokana.
VW Audi Recall
Seeger Weiss LLP is investigating Volkswagen and Audi for environmental violations of diesel-powered vehicles.
Seeger Weiss LLP is offering free consultations for patients who have suffered injuries from the drug Onglyza.
IVC Filter Lawsuit
Seeger Weiss LLP is investigating serious complications and injuries resulting from the use of IVC filters.
The FDA issued a warning after studies showed that older men may have twice the normal heart attack risk.
Seeger Weiss LLP is investigating claims that Zofran has been linked to birth defects involving cleft lip and congenital heart defects.
Within two years of coming to market, nearly 700 serious adverse reaction were reported including several deaths.
Seeger Weiss is investigating claims for a class action suit against Volkswagen and Audi related to a defective Timing Chain Tensioner System (“Tensioner System”) in all 2008 through 2013 model year vehicles [...]May 20, by: Seeger Weiss read more
OUR ROLE: Christopher A. Seeger, principal partner and co-founder of Seeger Weiss LLP, has been appointed to serve on the Plaintiffs’ Steering Committee, and as State Court Liaison Counsel, in the most [...]May 11, by: Seeger Weiss read more